Study guide
8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
Key Takeaways Explain This Topic AI
Oregon pharmacists must document, quarantine and physically separate recalled, outdated, damaged, misbranded, adulterated, counterfeit or suspect drugs until they are destroyed or returned.
An Oregon pharmacy may not dispense a drug that will expire before the course of therapy ends, or one obtained from a source not registered in Oregon.
Oregon pharmacists, technicians and interns may never accept returns of controlled substances; patients use take-back receptacles or mail-back instead.
In Oregon, returned drugs may be redispensed only if unopened, tamper-evident and kept in a long-term care or supervised-living setting under consultant-pharmacist oversight.
Oregon's Charitable Prescription Drug Program redistributes sealed donated drugs with lot and expiration dates to needy patients, but only if they expire at least nine months after donation.
Last updated: October 2026
Why this matters
Area 3.7 covers "drug product conditions prohibiting dispensing," and Area 2.4 covers "returning or reusing drugs." The two are linked. A product that has left pharmacy control, or is adulterated, misbranded, expired, recalled, suspect or improperly stored, generally cannot be dispensed. Oregon has explicit rules on quarantine, returns and limited redispensing.
Conditions that prohibit dispensing
Condition Legal basis What the pharmacist does
Adulterated (contaminated, not made under cGMP, below USP strength or purity, stored improperly) FDCA 501 (21 U.S.C. 351); ORS 689.527(3)–(4) Quarantine; do not dispense
Misbranded (false or misleading label, missing required information or warnings) FDCA 502 (21 U.S.C. 352); ORS 689.505 Quarantine; do not dispense
- Outdated , or will expire before the course of therapy ends OAR 855-041-1130 (see note) Do not dispense
- Recalled FDA recall classes I–III Quarantine and follow the recall notice
Counterfeit, suspect or illegitimate (DSCSA) 21 U.S.C. 360eee-1 Quarantine, investigate, notify FDA and trading partners within 24 hours if illegitimate (section 11.2)
Temperature excursion not cleared as safe OAR 855-041-1036(2)(b) Quarantine until the pharmacist decides, using a documented source, whether it is safe or must be destroyed
Acquired from an unregistered source OAR 855-115-0125(3) Do not dispense; drugs must come from an Oregon-registered outlet
Damaged after a fire, flood or power loss OAR 855-007-0120; ORS 689.135(14) Treat as adulterated unless shown to be safe; the Board may embargo
Quarantine rule: drugs and devices that are recalled, outdated, damaged, deteriorated, misbranded, adulterated, counterfeit, suspect or illegitimate, or otherwise unfit, must be documented, quarantined and physically separated until destroyed or returned to the supplier (OAR 855-115-0125(5); OAR 855-041-1036(1)(d); OAR 855-041-1025). The Board's self-inspection form asks where the quarantine area is and how quarantined controlled substances are kept secure.
FDA recall classes
Class I: a reasonable probability of serious adverse health consequences or death.
Class II: may cause temporary or medically reversible effects, or the chance of serious harm is remote.
Class III: unlikely to cause adverse health consequences.
Pharmacies follow the recall's depth (wholesale, retail or consumer), quarantine the stock and contact patients when the recall reaches the consumer level.
Returned drugs (OAR 855-041-1045)
Controlled substances: pharmacists, technicians and interns may not accept the return of controlled substances. A patient who wants to dispose of controlled substances uses an authorized collection receptacle (take-back), a mail-back package or a take-back event. Staff never handle the returned drugs (section 11.4).
Returns for destruction only: pharmacy personnel may accept a drug or device that left the pharmacy if it was:
Dispensed in error.
Defective, adulterated or misbranded.
Dispensed beyond its expiration date.
Undeliverable to the patient.
Subject to a recall.
A pharmacist may also accept a return when professional judgment says harm could result otherwise.
Return and redispensing: a previously dispensed drug may be returned to stock and redispensed only if :
It is in unopened, tamper-evident packaging.
It was kept under proper control in a long-term care or supervised-living setting with consultant pharmacist oversight.
It was stored per the manufacturer and is not adulterated or misbranded.
Will-call returns to stock , meaning prescriptions never picked up, never left the pharmacy, so they can return to inventory. A technician or intern who does this needs pharmacist verification documented, and the claim and any PDMP report are corrected as needed. A returned-to-stock prescription is removed from any auto-refill program (OAR 855-041-1120(6)).
Reuse through the Charitable Prescription Drug Program (ORS 689.770–689.780)
Oregon's Charitable Prescription Drug Program lets Board-registered, Board-approved outlets accept donated prescription drugs and distribute them to needy or uninsured people. Donations must be in original, sealed, tamper-evident packaging showing the lot number and expiration date . Sealed single-unit-dose packages from opened multi-dose cartons, and drugs repackaged by another charitable program, are also accepted. The program may not distribute drugs that:
Expire less than nine months after donation.
Are adulterated or misbranded.
Belong to a controlled-substance category the Board excludes by rule.
Participants who act in good faith are immune from liability (ORS 689.772, 689.780).
Warning
A patient's unopened, sealed box of insulin pens returned from home cannot be redispensed in an Oregon community pharmacy. The redispensing exception covers only drugs kept in long-term care or supervised-living settings under consultant-pharmacist control. Proper handling outside the pharmacy cannot be verified.
Exam scenario
A patient returns two items:
Unopened oxycodone tablets ("I don't need them"). The pharmacy may not accept them. Staff direct the patient to the pharmacy's DEA-authorized collection receptacle, which is in view of but not behind the counter, or to another disposal option.
A sealed albuterol inhaler dispensed in error last week (wrong patient). The pharmacist may accept it for destruction , because it was dispensed in error, but may not return it to stock for another patient.
The pharmacist documents both events.